Navigation Links
'Protected Classes' Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
Date:7/18/2012

WASHINGTON, July 18, 2012 /PRNewswire-USNewswire/ -- Imposing a federal "protected classes" prescription drug mandate on individual and small employer plans would raise premiums, grant drug companies unlimited pricing power, and create strong opposition from small businesses, the Pharmaceutical Care Management Association (PCMA) said today.  The Centers for Medicare & Medicaid Services (CMS) says a similar mandate is dramatically increasing costs in Medicare Part D.

In the commercial market, employers and unions negotiate discounts from drug companies in exchange for covering their drugs.  This reduces premiums and offers manufacturers a greater marketplace.  To simply force plans to cover expensive brands – regardless of price – would eliminate manufacturers' incentives to offer discounts.  The result would be higher costs and virtually unchecked pricing power for drug companies.

Unfortunately, "protected classes" regulations have already taken their toll on Medicare Part D.  CMS estimates that they will increase costs by $4.2 billion.  There is no corresponding evidence that Medicare beneficiaries' health or access to care has improved as a result.

In a recent survey, 66% of small employers say "cost" is their top consideration when considering health benefits.  Imposing "protected classes" would not only undermine affordability but also contradict the Department of Health and Human Services' (HHS) pronouncement that states can design benefits like those of popular, high-performing plans that local employers already use.  No such plans are governed by "protected classes" regulations.

"These 'protected class' mandates would grant drug companies unlimited pricing power and make coverage less affordable for individuals and small businesses.  Small businesses shouldn't have to choose between a bloated Cadillac plan and no plan at all.  They want access to affordable plans that offer broad coverage, promote generics, and reduce brand name drug costs," said PCMA President and CEO Mark Merritt.

The poll of small business owners and human resource managers (who represent the companies directly impacted by the upcoming Essential Health Benefits regulations) found that:

  • Small businesses want low-cost coverage options, not mandatory "Cadillac coverage." Their top priorities are low pharmacy costs for their business (66 percent) and lower out-of-pocket costs for their employees (39 percent). Given a choice, they prefer basic coverage with lower premiums (71 percent) to expanded coverage with higher premiums (19 percent).
  • Small businesses that provide drug benefits are overwhelmingly satisfied with the benefits that they are able to offer. By an 86 to 11 percent margin, small businesses that provide drug benefits are satisfied with those benefits.
  • Seventy-four percent oppose mandating across-the-board, low co-pays for high-priced drugs. By a 2-1 margin, small businesses think it would be better to require drug companies to offer case-by-case price discounts to those in need.
  • Small businesses want access to plans that encourage delivery of prescription drugs through the mail. 79 percent say it is a good idea to "allow plans to offer discounts that encourage employees to get prescriptions by mail."

The survey echoes concerns outlined by the Essential Health Benefits Coalition (an employer led coalition comprised of the National Federation of Independent Business, the National Retail Federation, and others) and Administration policy that commercial practice would be the benchmark for essential health benefits for prescription drugs.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve
affordability and quality of care through the use of electronic prescribing (e-prescribing),
generic alternatives, mail-service pharmacies, and other innovative tools for 216 million Americans.

Follow PCMA on Twitter


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
2. President Obama Signs Landmark Accessible Prescription Drug Label Bill
3. New Video, Website Help Health Plan Sponsors, Patients and Policy Makers Maximize Prescription Drug Benefits, Reduce Wasteful Spending
4. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
5. Partnership Aims to Prevent Students from Misusing Prescription Drugs
6. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
7. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
8. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
9. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
10. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
11. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... -- Halo Labs announces the launch of a novel ... the Horizon at PEGS 2017 in Boston ... sub visible particulate matter in biopharmaceutical samples to enable ... as candidate selection and pre-formulation. Halo Labs ... Elion Labs for system validation. "We are ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology:
(Date:4/26/2017)... , ... April 26, 2017 , ... ... to improve the profitability of ready-to-drink, high-protein beverages by helping beverage manufacturers more ... to dairy proteins, providing direct cost savings as well as more stable pricing ...
(Date:4/25/2017)... ... 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... physical therapy provider for Derby City CrossFit, effective immediately. , In addition to ... and effectively as possible, ProRehab’s sports physical therapists will work with athletes to ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental are now ... fear and require sedation to receive dental care. The doctors offer three treatment options ... hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... a reputable physician in their area, announces the launch of a new and proprietary ... who are looking for reputable physicians to help them with back or neck pain ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South Florida ... report in the May issue of Consumer Reports focused on heart health. , ... achieved during and after coronary bypass and aortic valve replacement procedures. , Consumer ...
Breaking Medicine News(10 mins):